دورية أكاديمية
أعرض في EDS

Opioid prescription trends among American Head and Neck Society fellowship graduates.

التفاصيل البيبلوغرافية
العنوان: Opioid prescription trends among American Head and Neck Society fellowship graduates.
المؤلفون: Patel R; Department of Otolaryngology-Head and Neck Surgery, Rutgers New Jersey Medical School, Newark, New Jersey, USA., Nguyen J; Department of Otolaryngology-Head and Neck Surgery, Rutgers New Jersey Medical School, Newark, New Jersey, USA., Choudhry HS; Department of Otolaryngology-Head and Neck Surgery, Rutgers New Jersey Medical School, Newark, New Jersey, USA., Lemdani MS; Department of Otolaryngology-Head and Neck Surgery, Rutgers New Jersey Medical School, Newark, New Jersey, USA., Park RCW; Department of Otolaryngology-Head and Neck Surgery, Rutgers New Jersey Medical School, Newark, New Jersey, USA.
المصدر: Head & neck [Head Neck] 2023 May; Vol. 45 (5), pp. 1113-1121. Date of Electronic Publication: 2023 Mar 01.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: John Wiley And Sons Country of Publication: United States NLM ID: 8902541 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0347 (Electronic) Linking ISSN: 10433074 NLM ISO Abbreviation: Head Neck Subsets: MEDLINE
أسماء مطبوعة: Publication: New York, NY : John Wiley And Sons
Original Publication: New York, NY : J. Wiley, c1989-
مواضيع طبية MeSH: Analgesics, Opioid*/therapeutic use , Fellowships and Scholarships*, Humans ; United States ; Aged ; Retrospective Studies ; Medicare ; Practice Patterns, Physicians' ; Drug Prescriptions
مستخلص: Background: Opioids are commonly used to manage the pain of head and neck (HN) cancer patients.
Methods: Retrospective cohort of graduates from American Head and Neck Society accredited fellowships from 1997 to 2018. The Center for Medicare and Medicaid Services Part D Provider Utilization and Payment database 2014-2019 was cross-referenced with provider names to identify opioid prescription trends.
Results: From 2014 to 2019, there was no significant difference in the average number of opioid beneficiaries per provider (18.02 vs. 18.10, p = 0.586) or opioid claims per provider (28.06 vs. 26.73, p = 0.708). The average total opioid day supply per beneficiary declined from 11.09 to 7.05 days from 2014 to 2019 (p < 0.001). In 2019, providers in the Northeast had the lowest prescribed opioid day supply (3.67 days) compared to those from the South who had the highest (10.32 days).
Conclusions: Opioid prescription length has significantly declined among HN surgeons, with variations across geographic regions.
(© 2023 The Authors. Head & Neck published by Wiley Periodicals LLC.)
References: Brownstein MJ. A brief history of opiates, opioid peptides, and opioid receptors. Proc Natl Acad Sci U S A. 1993;90(12):5391-5393.
Schwartz MA, Naples JG, Kuo C-L, Falcone TE. Opioid prescribing patterns among otolaryngologists. Otolaryngol Head Neck Surg. 2018;158(5):854-859.
Ing JW. Head and neck cancer pain. Otolaryngol Clin North Am. 2017;50(4):793-806. doi:10.1016/j.otc.2017.04.001.
Basilico M, Bhashyam AR, Harris MB, Heng M. Prescription opioid type and the likelihood of prolonged opioid use after orthopaedic surgery. JAAOS J Am Acad Orthop Surg. 2019;27(9):e423-e429.
Barbarite E, Occhiogrosso J, McCarty JC, et al. Opioid prescribing patterns among facial plastic and reconstructive surgeons in the Medicare population. Facial Plast Surg Aesthet Med. 2021;23(6):401-404.
Zgierska A, Miller M, Rabago D. Patient satisfaction, prescription drug abuse, and potential unintended consequences. JAMA. 2012;307(13):1377-1378.
Boylan MR, Suchman KI, Slover JD, Bosco JA. Patterns of narcotic prescribing by orthopedic surgeons for Medicare patients. Am J Med Qual. 2018;33(6):637-641.
Health UDo, General HSOotI. Opioid Use in Medicare Part D Remains Concerning. Accessed May 12, 2022. https://oig.hhs.gov/oei/reports/oei-02-18-00220.asp.
Romman AN, Hsu CM, Chou L-N, et al. Opioid prescribing to Medicare Part D enrollees, 2013-2017: shifting responsibility to pain management providers. Pain Med. 2020;21(7):1400-1407.
Levy B, Paulozzi L, Mack KA, Jones CM. Trends in opioid analgesic-prescribing rates by specialty, US, 2007-2012. Am J Prev Med. 2015;49(3):409-413.
Murphey AW, Munawar S, Nguyen SA, Meyer TA, O'Rourke AK. Opioid prescribing patterns within otolaryngology. World J Otorhinolaryngol Head Neck Surg. 2019;5(2):112-116.
Svider PF, Arianpour K, Guo E, et al. Opioid prescribing patterns among otolaryngologists: crucial insights among the Medicare population. Laryngoscope. 2018;128(7):1576-1581.
Khalid SI, Adogwa O, Lilly DT, et al. Opioid prescribing practices of neurosurgeons: analysis of Medicare Part D. World Neurosurg. 2018;112:e31-e38.
Anne S, Mims JW, Tunkel DE, et al. Clinical practice guideline: opioid prescribing for analgesia after common otolaryngology operations. Otolaryngol Head Neck Surg. 2021;164(2 Suppl):S1-S42.
March JP, Lim JY, Manzione KL, Buncke M, Shindo ML. Association of a multimodal intervention with decreased opioid prescribing after neck dissection for malignant thyroid disease with short hospital stay. JAMA Otolaryngol Head Neck Surg. 2022;148(6):561-567.
Society AHaN. Graduates from AHNS-Accredited Programs. Accessed May 12, 2022. https://www.ahns.info/residentfellow/recent/.
Bureau USC. Geographic Levels. Accessed May 12, 2022. https://www.census.gov/programs-surveys/economic-census/guidance-geographies/levels.html.
Services CfMaM. Medicare Part D Prescribers. Provider Data Dictionary; 2020.
Macfarlane TV, Wirth T, Ranasinghe S, Ah-See KW, Renny N, Hurman D. Head and neck cancer pain: systematic review of prevalence and associated factors. J Oral Maxillofac Res. 2012;3(1):e1. doi:10.5037/jomr.2012.3101.
Kriplani A, Lavery JA, Mishra A, et al. Trends in chronic opioid therapy among survivors of head and neck cancer. Head Neck. 2021;43(1):223-228. doi:10.1002/hed.26478.
Cata JP, Patino M, Gorur A, et al. Persistent and chronic postoperative opioid use in a cohort of patients with oral tongue squamous cell carcinoma. Pain Med. 2020;21(5):1061-1067.
Schumacher LD, Sargi ZB, Masforroll M, et al. Long-term opioid use in curative-intent radiotherapy: one-year outcomes in head/neck cancer patients. Head Neck. 2020;42(4):608-624. doi:10.1002/hed.26034.
Sethi RKV, Panth N, Puram SV, Varvares MA. Opioid prescription patterns among patients with head and neck cancer. JAMA Otolaryngol Head Neck Surg. 2018;144(4):382-383. doi:10.1001/jamaoto.2017.3343.
Patel NA, Keith DA. Five-year comparative analysis of Medicare opioid prescription volume among oral and maxillofacial surgeons. J Oral Maxillofac Surg. 2019;77(12):2439-2446.
Scherrer JF, Tucker J, Salas J, Zhang Z, Grucza R. Comparison of opioids prescribed for patients at risk for opioid misuse before and after publication of the Centers for Disease Control and Prevention's opioid prescribing guidelines. JAMA Netw Open. 2020;3(12):e2027481. doi:10.1001/jamanetworkopen.2020.27481.
Haider A, Zhukovsky DS, Meng YC, et al. Opioid prescription trends among patients with cancer referred to outpatient palliative care over a 6-year period. J Oncol Pract. 2017;13(12):e972-e981.
Flanagan CD, Joseph NM, Benedick A, Vallier HA. Five-year trends in opioid prescribing following orthopaedic trauma. J Am Acad Orthop Surg Glob Res Rev. 2020;4(8):e20.00134. doi:10.5435/JAAOSGlobal-D-20-00134.
Marrache M, Best MJ, Raad M, Mikula JD, Amin RM, Wilckens JH. Opioid prescribing trends and geographic variation after anterior cruciate ligament reconstruction. Sports Health. 2020;12(6):528-533.
Bao Y, Pan Y, Taylor A, et al. Prescription drug monitoring programs are associated with sustained reductions in opioid prescribing by physicians. Health Aff. 2016;35(6):1045-1051.
Paulozzi LJ, Kilbourne EM, Desai HA. Prescription drug monitoring programs and death rates from drug overdose. Pain Med. 2011;12(5):747-754.
Yarbrough CR. Prescription drug monitoring programs produce a limited impact on painkiller prescribing in Medicare Part D. Health Serv Res. 2018;53(2):671-689.
Trusts PC. When Are Prescribers Required to Use Prescription Drug Monitoring Programs. 2022. Accessed May 12, 2022. https://www.pewtrusts.org/en/research-and-analysis/data-visualizations/2018/when-are-prescribers-required-to-use-prescription-drug-monitoring-programs.
Hill MV, McMahon ML, Stucke RS, Barth RJ. Wide variation and excessive dosage of opioid prescriptions for common general surgical procedures. Ann Surg. 2017;265(4):709-714.
Bicket MC, Long JJ, Pronovost PJ, Alexander GC, Wu CL. Prescription opioid analgesics commonly unused after surgery: a systematic review. JAMA Surg. 2017;152(11):1066-1071.
Feinberg AE, Chesney TR, Srikandarajah S, Acuna SA, McLeod RS. Opioid use after discharge in postoperative patients: a systematic review. Ann Surg. 2018;267(6):1056-1062.
Neuman MD, Bateman BT, Wunsch H. Inappropriate opioid prescription after surgery. Lancet. 2019;393(10180):1547-1557.
Sabatino MJ, Kunkel ST, Ramkumar DB, Keeney BJ, Jevsevar DS. Excess opioid medication and variation in prescribing patterns following common orthopaedic procedures. J Bone Joint Surg Am. 2018;100(3):180-188.
Gostin LO, Hodge JG, Noe SA. Reframing the opioid epidemic as a national emergency. JAMA. 2017;318(16):1539-1540.
Arianpour K, Nguyen B, Yuhan B, Svider PF, Eloy JA, Folbe AJ. Opioid prescription among sinus surgeons. Am J Rhinol Allergy. 2018;32(4):323-329.
Santosa KB, Wang CS, Hu H-M, Brummett CM, Englesbe MJ, Waljee JF. Surgeon experience and opioid prescribing. Am J Surg. 2020;220(4):823-827. doi:10.1016/j.amjsurg.2020.06.013.
Huang N, Cunningham F, Laurito CE, Chen C. Can we do better with postoperative pain management? Am J Surg. 2001;182(5):440-448. doi:10.1016/s0002-9610(01)00766-8.
Perlis RH, Perlis CS. Physician payments from industry are associated with greater Medicare Part D prescribing costs. PLoS One. 2016;11(5):e0155474.
Venker B, Stephenson KB, Gellad WF. Assessment of spending in Medicare Part D if medication prices from the Department of Veterans Affairs were used. JAMA Intern Med. 2019;179(3):431-433.
Ziakas PD, Kourbeti IS, Poulou LS, Vlachogeorgos GS, Mylonakis E. Medicare Part D prescribing for direct oral anticoagulants in the United States: cost, use and the “rubber effect”. PLoS One. 2018;13(6):e0198674.
فهرسة مساهمة: Keywords: day supply; drug cost; head and neck surgeons; opioids; prescription trend
المشرفين على المادة: 0 (Analgesics, Opioid)
تواريخ الأحداث: Date Created: 20230302 Date Completed: 20230407 Latest Revision: 20230410
رمز التحديث: 20231215
DOI: 10.1002/hed.27312
PMID: 36859787
قاعدة البيانات: MEDLINE
الوصف
تدمد:1097-0347
DOI:10.1002/hed.27312